Main objective: Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load.
Main objective
• Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load monitoring
Secondary objectives
• Description of success/failure clinico-immunological criteria at 24 months and at 6, 12 and 18 months
• Identification of the reasons for virological failure at 24 months
• Description of resistance mutations to ARV observed at 24 months
• Analysis of the observance of the patients still on ARV at 24 months
• Evaluation of ARV side-effects during the 24 months of treatment
• Pharmacological analysis of ARV at 24 months
